Obstet Gynecol Sci.  2019 Jan;62(1):1-10. 10.5468/ogs.2019.62.1.1.

Could surgical management improve the IVF outcomes in infertile women with endometrioma?: a review

• Park HJ
• Kim H
• Lee GH
• Yoon TK
• Lee WS

• KMID: 2430924
• DOI: http://doi.org/10.5468/ogs.2019.62.1.1

Abstract

Endometriosis is a chronic inflammatory condition that affects fertility and could be toxic to the ovary. Endometrioma per se and surgical interventions for endometrioma significantly reduce the ovarian reserve. Therefore, to prepare for surgical intervention for endometrioma, the high-risk group with decreased ovarian reserve must be considered. There is no evidence to support the use of surgical intervention before in vitro fertilization (IVF) to improve the reproductive outcomes of subsequent IVF in infertile women with advanced-stage endometriosis or endometrioma. As surgical treatment has few benefits, IVF could be recommended immediately for aiding conception in these women. However, the reproductive prognosis of IVF may be worse in the more advanced stages of endometriosis. When dysmenorrhea is severe or when cancer is suspected, surgery prior to IVF may be necessary and justified. When the size of the endometrioma is very large, surgery could be required prior to IVF to facilitate access to follicles during oocyte retrieval or to improve the ovarian response to controlled ovarian stimulation. Prolonged pituitary downregulation in women with surgically diagnosed endometriosis may be helpful to increase the clinical pregnancy rate in subsequent IVF cycles. The purpose of this paper was to review the efficiency and clinical application of the surgical intervention and IVF for infertile women with advanced-stage endometriosis or endometrioma.

Keyword

Endometriosis; In vitro fertilization; Laparoscopy; Cystectomy; Infertility

MeSH Terms

Cystectomy
Down-Regulation
Dysmenorrhea
Endometriosis*
Female
Fertility
Fertilization
Fertilization in Vitro
Humans
Infertility
Laparoscopy
Oocyte Retrieval
Ovarian Reserve
Ovary
Ovulation Induction
Pregnancy Rate
Prognosis

Reference

1. Ozkan S, Murk W, Arici A. Endometriosis and infertility: epidemiology and evidence-based treatments. Ann N Y Acad Sci. 2008; 1127:92–100. PMID: 18443335.

2. Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2013 assisted reproductive technology national summary report [Internet]. Atlanta (GA): US Department of Health and Human Services;2015. cited 2016 Dec 1. Available from: http://www.cdc.gov/art/pdf/2013-report/art_2013_national_summary_report.pdf.

3. Singh SS, Suen MW. Surgery for endometriosis: beyond medical therapies. Fertil Steril. 2017; 107:549–554. PMID: 28189295.

4. Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D'Hooghe T, De Bie B, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014; 29:400–412. PMID: 24435778.

5. Marcoux S, Maheux R, Bérubé S. Canadian Collaborative Group on Endometriosis. Laparoscopic surgery in infertile women with minimal or mild endometriosis. N Engl J Med. 1997; 337:217–222. PMID: 9227926.

6. Ruiz-Flores FJ, Garcia-Velasco JA. Is there a benefit for surgery in endometrioma-associated infertility? Curr Opin Obstet Gynecol. 2012; 24:136–140. PMID: 22327738.

7. Garcia-Velasco JA, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod. 2009; 24:496–501. PMID: 19056774.

8. American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997; 67:817–821. PMID: 9130884.

9. Iizuka M, Igarashi M, Abe Y, Ibuki Y, Koyasu Y, Ikuma K. Chemical assay of iron in ovarian cysts: a new diagnostic method to evaluate endometriotic cysts. Gynecol Obstet Invest. 1998; 46:58–60. PMID: 9692345.

10. Yamaguchi K, Mandai M, Toyokuni S, Hamanishi J, Higuchi T, Takakura K, et al. Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress. Clin Cancer Res. 2008; 14:32–40. PMID: 18172249.

11. Iwabuchi T, Yoshimoto C, Shigetomi H, Kobayashi H. Oxidative stress and antioxidant defense in endometriosis and its malignant transformation. Oxid Med Cell Longev. 2015; 2015:848595. PMID: 26185594.

12. Vercellini P, Crosignani P, Somigliana E, Viganò P, Buggio L, Bolis G, et al. The ‘incessant menstruation' hypothesis: a mechanistic ovarian cancer model with implications for prevention. Hum Reprod. 2011; 26:2262–2273. PMID: 21724568.

13. Matsuzaki S, Schubert B. Oxidative stress status in normal ovarian cortex surrounding ovarian endometriosis. Fertil Steril. 2010; 93:2431–2432. PMID: 19819438.

14. Zhang X, Li XH, Ma X, Wang ZH, Lu S, Guo YL. Redox-induced apoptosis of human oocytes in resting follicles in vitro . J Soc Gynecol Investig. 2006; 13:451–458.

15. Sanchez AM, Viganò P, Somigliana E, Panina-Bordignon P, Vercellini P, Candiani M. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Hum Reprod Update. 2014; 20:217–230. PMID: 24129684.

16. Qiu JJ, Liu YL, Liu MH, Chen LP, Xu DW, Zhang ZX, et al. Ovarian interstitial blood flow changes assessed by transvaginal colour Doppler sonography: predicting ovarian endometrioid cyst-induced injury to ovarian interstitial vessels. Arch Gynecol Obstet. 2012; 285:427–433. PMID: 21779780.

17. Simón C, Gutiérrez A, Vidal A, de los Santos MJ, Tarín JJ, Remohí J, et al. Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation. Hum Reprod. 1994; 9:725–729. PMID: 8046030.

18. Díaz I, Navarro J, Blasco L, Simón C, Pellicer A, Remohí J. Impact of stage III–IV endometriosis on recipients of sibling oocytes: matched case-control study. Fertil Steril. 2000; 74:31–34. PMID: 10899493.

19. Shebl O, Sifferlinger I, Habelsberger A, Oppelt P, Mayer RB, Petek E, et al. Oocyte competence in in vitro fertilization and intracytoplasmic sperm injection patients suffering from endometriosis and its possible association with subsequent treatment outcome: a matched case-control study. Acta Obstet Gynecol Scand. 2017; 96:736–744. PMID: 27317364.

20. Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril. 2002; 77:1148–1155. PMID: 12057720.

21. Harb HM, Gallos ID, Chu J, Harb M, Coomarasamy A. The effect of endometriosis on in vitro fertilisation outcome: a systematic review and meta-analysis. BJOG. 2013; 120:1308–1320. PMID: 23834505.

22. Hamdan M, Omar SZ, Dunselman G, Cheong Y. Influence of endometriosis on assisted reproductive technology outcomes: a systematic review and meta-analysis. Obstet Gynecol. 2015; 125:79–88. PMID: 25560108.

23. Yang C, Geng Y, Li Y, Chen C, Gao Y. Impact of ovarian endometrioma on ovarian responsiveness and IVF: a systematic review and meta-analysis. Reprod Biomed Online. 2015; 31:9–19. PMID: 25982092.

24. Romualdi D, Franco Zannoni G, Lanzone A, Selvaggi L, Tagliaferri V, Gaetano Vellone V, et al. Follicular loss in endoscopic surgery for ovarian endometriosis: quantitative and qualitative observations. Fertil Steril. 2011; 96:374–378. PMID: 21703608.

25. Kim JY, Jee BC, Suh CS, Kim SH. Preoperative serum anti-mullerian hormone level in women with ovarian endometrioma and mature cystic teratoma. Yonsei Med J. 2013; 54:921–926. PMID: 23709427.

26. Somigliana E, Berlanda N, Benaglia L, Viganò P, Vercellini P, Fedele L. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications. Fertil Steril. 2012; 98:1531–1538. PMID: 22975114.

27. Ata B, Uncu G. Impact of endometriomas and their removal on ovarian reserve. Curr Opin Obstet Gynecol. 2015; 27:235–241. PMID: 25760984.

28. Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012; 97:3146–3154. PMID: 22723324.

29. Uncu G, Kasapoglu I, Ozerkan K, Seyhan A, Oral Yilmaztepe A, Ata B. Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve. Hum Reprod. 2013; 28:2140–2145. PMID: 23624580.

30. Urman B, Alper E, Yakin K, Oktem O, Aksoy S, Alatas C, et al. Removal of unilateral endometriomas is associated with immediate and sustained reduction in ovarian reserve. Reprod Biomed Online. 2013; 27:212–216. PMID: 23768623.

31. Goodman LR, Goldberg JM, Flyckt RL, Gupta M, Harwalker J, Falcone T. Effect of surgery on ovarian reserve in women with endometriomas, endometriosis and controls. Am J Obstet Gynecol. 2016; 215:589.e1–589.e6. PMID: 27242204.

32. Chen Y, Pei H, Chang Y, Chen M, Wang H, Xie H, et al. The impact of endometrioma and laparoscopic cystectomy on ovarian reserve and the exploration of related factors assessed by serum anti-Mullerian hormone: a prospective cohort study. J Ovarian Res. 2014; 7:108. PMID: 25424986.

33. Roustan A, Perrin J, Debals-Gonthier M, Paulmyer-Lacroix O, Agostini A, Courbiere B. Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome. Hum Reprod. 2015; 30:840–847. PMID: 25740883.

34. Hong SB, Lee NR, Kim SK, Kim H, Jee BC, Suh CS, et al. In vitro fertilization outcomes in women with surgery induced diminished ovarian reserve after endometrioma operation: comparison with diminished ovarian reserve without ovarian surgery. Obstet Gynecol Sci. 2017; 60:63–68. PMID: 28217673.

35. Maignien C, Santulli P, Gayet V, Lafay-Pillet MC, Korb D, Bourdon M, et al. Prognostic factors for assisted reproductive technology in women with endometriosis-related infertility. Am J Obstet Gynecol. 2017; 216:280.e1–280.e9. PMID: 27899313.

36. Alborzi S, Keramati P, Younesi M, Samsami A, Dadras N. The impact of laparoscopic cystectomy on ovarian reserve in patients with unilateral and bilateral endometriomas. Fertil Steril. 2014; 101:427–434. PMID: 24269044.

37. Muzii L, Achilli C, Lecce F, Bianchi A, Franceschetti S, Marchetti C, et al. Second surgery for recurrent endometriomas is more harmful to healthy ovarian tissue and ovarian reserve than first surgery. Fertil Steril. 2015; 103:738–743. PMID: 25577464.

38. Ferrero S, Scala C, Racca A, Calanni L, Remorgida V, Venturini PL, et al. Second surgery for recurrent unilateral endometriomas and impact on ovarian reserve: a case-control study. Fertil Steril. 2015; 103:1236–1243. PMID: 25681854.

39. Park H, Kim CH, Kim EY, Moon JW, Kim SH, Chae HD, et al. Effect of second-line surgery on in vitro fertilization outcome in infertile women with ovarian endometrioma recurrence after primary conservative surgery for moderate to severe endometriosis. Obstet Gynecol Sci. 2015; 58:481–486. PMID: 26623412.

40. Xing W, Lin H, Wu Z, Li Y, Zhang Q. Effect of pelvic endometriosis, endometriomas and recurrent endometriomas on IVF-ET/ICSI outcomes. Mater Sociomed. 2016; 28:91–94. PMID: 27147911.

41. Hamdan M, Dunselman G, Li TC, Cheong Y. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis. Hum Reprod Update. 2015; 21:809–825. PMID: 26168799.

42. Tao X, Chen L, Ge S, Cai L. Weigh the pros and cons to ovarian reserve before stripping ovarian endometriomas prior to IVF/ICSI: a meta-analysis. PLoS One. 2017; 12:e0177426. PMID: 28574993.

43. Hart RJ, Hickey M, Maouris P, Buckett W. Excisional surgery versus ablative surgery for ovarian endometriomata. Cochrane Database Syst Rev. 2008; CD004992. PMID: 18425908.

44. Benschop L, Farquhar C, van der Poel N, Heineman MJ. Interventions for women with endometrioma prior to assisted reproductive technology. Cochrane Database Syst Rev. 2010; CD008571. PMID: 21069706.

45. Somigliana E, Vercellini P, Viganó P, Ragni G, Crosignani PG. Should endometriomas be treated before IVF-ICSI cycles? Hum Reprod Update. 2006; 12:57–64. PMID: 16155094.

46. Tanbo T, Fedorcsak P. Endometriosis-associated infertility: aspects of pathophysiological mechanisms and treatment options. Acta Obstet Gynecol Scand. 2017; 96:659–667. PMID: 27998009.

47. Giacomini E, Sanchez AM, Sarais V, Beitawi SA, Candiani M, Viganò P. Characteristics of follicular fluid in ovaries with endometriomas. Eur J Obstet Gynecol Reprod Biol. 2017; 209:34–38. PMID: 26895700.

48. Cooney LG, Mainigi MA. Surgery for endometriomas before IVF: what are the benefits and risks? Minerva Ginecol. 2015; 67:195–205. PMID: 25690492.

49. Soriano D, Adler I, Bouaziz J, Zolti M, Eisenberg VH, Goldenberg M, et al. Fertility outcome of laparoscopic treatment in patients with severe endometriosis and repeated in vitro fertilization failures. Fertil Steril. 2016; 106:1264–1269. PMID: 27343955.

50. Reinblatt SL, Ishai L, Shehata F, Son WY, Tulandi T, Almog B. Effects of ovarian endometrioma on embryo quality. Fertil Steril. 2011; 95:2700–2702. PMID: 21444070.

51. Sallam HN, Garcia-Velasco JA, Dias S, Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev. 2006; CD004635. PMID: 16437491.

52. Taketani Y, Kuo TM, Mizuno M. Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis. Am J Obstet Gynecol. 1992; 167:265–270. PMID: 1442940.

53. Wu MY, Chen SU, Chao KH, Chen CD, Yang YS, Ho HN. Mouse embryo toxicity of IL-6 in peritoneal fluids from women with or without endometriosis. Acta Obstet Gynecol Scand. 2001; 80:7–11. PMID: 11167181.

54. Gómez-Torres MJ, Acién P, Campos A, Velasco I. Embryotoxicity of peritoneal fluid in women with endometriosis. Its relation with cytokines and lymphocyte populations. Hum Reprod. 2002; 17:777–781. PMID: 11870135.

55. Ruan HC, Zhu XM, Luo Q, Liu AX, Qian YL, Zhou CY, et al. Ovarian stimulation with GnRH agonist, but not GnRH antagonist, partially restores the expression of endometrial integrin β3 and leukaemia-inhibitory factor and improves uterine receptivity in mice. Hum Reprod. 2006; 21:2521–2529. PMID: 16790614.

56. Strowitzki T, Faustmann T, Gerlinger C, Seitz C. Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol. 2010; 151:193–198. PMID: 20444534.

57. Muller V, Kogan I, Yarmolinskaya M, Niauri D, Gzgzyan A, Aylamazyan E. Dienogest treatment after ovarian endometrioma removal in infertile women prior to IVF. Gynecol Endocrinol. 2017; 33:18–21. PMID: 29264985.

58. Hayashi A, Tanabe A, Kawabe S, Hayashi M, Yuguchi H, Yamashita Y, et al. Dienogest increases the progesterone receptor isoform B/A ratio in patients with ovarian endometriosis. J Ovarian Res. 2012; 5:31. PMID: 23113924.

59. AlKudmani B, Gat I, Buell D, Salman J, Zohni K, Librach C, et al. In vitro fertilization success rates after surgically treated endometriosis and effect of time interval between surgery and in vitro fertilization. J Minim Invasive Gynecol. 2018; 25:99–104. PMID: 28807807.

60. Somigliana E, Vigano P, Benaglia L, Busnelli A, Berlanda N, Vercellini P. Management of endometriosis in the infertile patient. Semin Reprod Med. 2017; 35:31–37. PMID: 27926972.